🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the manufacturers of acetaminophen, alleging the companies hid safety concerns that the medication created to children's brain development.

The court filing arrives thirty days after President Donald Trump advocated an unverified association between using Tylenol - also known as paracetamol - during pregnancy and autism in young ones.

The attorney general is suing the pharmaceutical giant, which previously sold the medication, the exclusive pain medication approved for women during pregnancy, and Kenvue, which now manufacturers it.

In a official comment, he claimed they "betrayed America by profiting off of discomfort and promoting medication ignoring the risks."

The manufacturer says there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering countless individuals to line their pockets," the attorney general, from the Republican party, said.

The manufacturer said in a statement that it was "deeply concerned by the perpetuation of misinformation on the reliability of paracetamol and the likely effects that could have on the welfare of US mothers and children."

On its website, Kenvue also mentioned it had "consistently assessed the relevant science and there is insufficient valid information that shows a verified association between taking paracetamol and autism."

Organizations acting on behalf of physicians and healthcare providers share this view.

ACOG has declared acetaminophen - the primary component in acetaminophen - is one of the few options for women during pregnancy to manage discomfort and elevated temperature, which can pose major wellness concerns if left untreated.

"In more than two decades of studies on the utilization of paracetamol in pregnancy, no reliable research has successfully concluded that the use of paracetamol in any stage of gestation results in brain development issues in children," the group said.

The court filing references recent announcements from the Trump administration in asserting the drug is allegedly unsafe.

Recently, Trump raised alarms from public health officials when he instructed women during pregnancy to "struggle intensely" not to use Tylenol when ill.

The FDA then issued a notice that physicians should consider limiting the use of Tylenol, while also declaring that "a proven link" between the medication and autism spectrum disorder in young ones has not been proven.

The Health Department head Kennedy, who oversees the Food and Drug Administration, had pledged in spring to undertake "comprehensive study program" that would determine the source of autism in a short period.

But specialists advised that identifying a single cause of autism - believed by scientists to be the outcome of a intricate combination of genetic and surrounding conditions - would be difficult.

Autism spectrum disorder is a category of permanent neurological difference and impairment that influences how persons experience and engage with the environment, and is identified using doctors' observations.

In his legal document, Paxton - aligned with the former president who is campaigning for federal office - alleges the manufacturer and J&J "willfully ignored and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the corporations "remove any marketing or advertising" that asserts Tylenol is reliable for pregnant women.

This legal action echoes the grievances of a collection of guardians of children with autism and attention deficit hyperactivity disorder who sued the makers of Tylenol in two years ago.

Judicial authorities dismissed the lawsuit, stating investigations from the family's specialists was not conclusive.